Publication | Closed Access

The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer

Metastatic Breast CancerBreast OncologyMedicinePharmacologyProton Pump InhibitorsBreast CancerPharmacotherapyCancer TreatmentCdk 4/6Oncology